還記得疫情期間的的「天國一輝」四大生技股？更難忘美時、藥華藥、北極星等生技行情，甚至在 AI 題材之前，很長一段時間生技都是指數護盤題材。 即使疫情結束，生病還是要吃藥，即使沒病也有醫美上的需求。隨著產業經歷大半年的整理，又有哪些生技股價值出現？ 本集【財富狂犇】邀請具備生技產業經驗的陳秀芳分析師，分享她對生技產業績優股的看法。 生技股為什麼能超脫景氣影響 生技「CDMO」業務四檔減肥概念股+兩檔隱藏電子股2024 新藥題材無法追題材的話，可以買生技ETF嗎 若需搭配線圖影像，可前往 Youtube 觀看 https://youtu.be/6JpjBe92qyM 留言告訴我你對這一集的想法： https://open.firstory.me/user/ckgt4pmfa3cjt0812r7uko63o/comments 楚狂人telegram 楚狂人FB 楚狂人終極投資組合策略課程介紹 Powered by Firstory Hosting
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
SpaceX Said to Pursue 2026 IPO
10 Dec 2025
Bloomberg Tech
Don’t Call It a Comeback
10 Dec 2025
Motley Fool Money
Japan Claims AGI, Pentagon Adopts Gemini, and MIT Designs New Medicines
10 Dec 2025
The Daily AI Show
Eric Larsen on the emergence and potential of AI in healthcare
10 Dec 2025
McKinsey on Healthcare
What it will take for AI to scale (energy, compute, talent)
10 Dec 2025
Azeem Azhar's Exponential View
Reducing Burnout and Boosting Revenue in ASCs
10 Dec 2025
Becker’s Healthcare -- Spine and Orthopedic Podcast